We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,165 results
  1. Volatile Oil from Magnolia sieboldii Improve Neurotransmitter Disturbance and Enhance the Sleep-Promoting Effect in p-Chlorophenylalanine-Induced Sleep-Deprived Mice

    Sleep-promoting effects of Magnolia sieboldii K.Koch, Magnoliaceae, volatile oils and elucidate their potential mechanisms in Kunming mice with p -chlo...

    Yong Ai, Minghui Tang, ... Tinggang He in Revista Brasileira de Farmacognosia
    Article 13 September 2023
  2. Modulating role of serotonergic signaling in sleep and memory

    Serotonin is an important neurotransmitter with various receptors and wide-range effects on physiological processes and cognitive functions including...

    Salar Vaseghi, Shirin Arjmandi-Rad, ... Mohammad-Reza Zarrindast in Pharmacological Reports
    Article 06 November 2021
  3. The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients

    Background

    The role of circadian rhythm abnormalities in patients with inflammatory bowel disease (IBD) remains relatively unknown. The aim of this...

    Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk, ... Jakub Fichna in Pharmacological Reports
    Article Open access 25 October 2021
  4. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis

    Rationale

    Recently, the effects of ketamine on the circadian rhythm have suggested that ketamine’s rapid antidepressant effects are associated with...

    Mingqia Wang, Bin Zhang, ... Yu** Ning in Pharmacological Reports
    Article 02 January 2021
  5. An Innovative Stress-Protective and Detoxification Substance for Reducing the Central Nervous System Effects of Alcohol Intoxication

    The search for new drugs to reduce the toxic effects of alcohol on the body is based on the creation of various pharmaceutical agents that affect the...

    T. V. Shushpanova, T. P. Novozheeva, ... E. M. Knyazeva in Pharmaceutical Chemistry Journal
    Article 01 October 2023
  6. Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder

    Background

    The understanding of mechanisms underlying non-response to antidepressants is limited. The latest data highlights the role of insulin...

    Anna J. Krupa, Adrian A. Chrobak, ... Marcin Siwek in Pharmacological Reports
    Article Open access 09 July 2024
  7. The effect of alpha lipoic acid on passive avoidance and social interaction memory, pain perception, and locomotor activity in REM sleep-deprived rats

    Background

    Evidence shows the vital role of sleep in the modulation of cognitive functions. Sleep deprivation (SD) can disrupt learning and memory...

    Mohadese Sadat Mahdavi, Mohammad Nasehi, ... Mohammad-Reza Zarrindast in Pharmacological Reports
    Article 30 September 2020
  8. Consider fibromyalgia in older patients with chronic widespread pain

    Fibromyalgia (FM) is a chronic condition involving widespread pain and usually fatigue and/or sleep problems. It can significantly decrease patients’...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 22 August 2022
  9. Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use

    Fezolinetant (VEOZAH ; Veoza ), a first-in-class neurokinin 3 receptor (NK3R) antagonist, represents a promising novel non-hormonal treatment option...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 27 May 2024
  10. Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem

    Background

    Anxiolytic benzodiazepines, due to their clinical effectiveness, are one of the most prescribed drugs worldwide, despite being associated...

    Hélder Fernandes, Vânia Batalha, ... Patrício Soares-da-Silva in Pharmacological Reports
    Article 12 September 2022
  11. Pharmacological management of psychoactive substance withdrawal syndrome

    Rationale

    Medications are available to manage alcohol and drug withdrawal, but they are underutilized. Only a handful, such as methadone,...

    Dimy Fluyau, Sarah Clare Cook, ... Neelambika Revadigar in Drugs & Therapy Perspectives
    Article 19 October 2021
  12. The treatment of post-traumatic nightmares requires more attention

    Nightmares are common and persistent in post-traumatic stress disorder (PTSD). These post-traumatic nightmares (PTNs) are resistant to general PTSD...

    Esther S. Kim, Connie Kang in Drugs & Therapy Perspectives
    Article 22 March 2023
  13. Long-term topical corticosteroid treatment for atopic dermatitis: an in-depth analysis of safety, efficacy, withdrawal, and patient experiences

    Atopic dermatitis, often referred to as eczema, is classified as a chronic inflammatory skin disorder with increasing prevalence. Topical...

    Alyssa Ingurgio in Drugs & Therapy Perspectives
    Article 09 July 2024
  14. Lemborexant in insomnia disorder: a profile of its use

    Lemborexant (Dayvigo™), a dual orexin receptor antagonist, is an effective and well-tolerated treatment option for adults with insomnia characterized...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 09 May 2020
  15. Can research on entactogens contribute to a deeper understanding of human sexuality?

    In recent years, scientific research into the therapeutic potential of psychedelic compounds has experienced a resurgence of interest. New studies...

    Justyna Holka-Pokorska in Pharmacological Reports
    Article Open access 08 November 2023
  16. Biopharmaceutics

    Biopharmaceutics, in connection with pharmacokinetics, is the field that investigates and describes everything that happens with a medicinal product...
    Henderik Frijlink, Frederic Lagarce, ... Herman Woerdenbag in Practical Pharmaceutics
    Chapter 2023
  17. Self-Therapy

    Most of our genetically defined disease risks will involve so many genes that it will be unrealistic to erase them from our body by gene therapy....
    Chapter 2022
  18. Amantadine extended release capsules (GOCOVRI®) in Parkinson’s disease: a profile of its use in the USA

    Amantadine extended release (ER) [GOCOVRI ® ], an NMDA receptor antagonist, is an important treatment option in the management of levodopa-induced...

    Zaina T. Al-Salama in Drugs & Therapy Perspectives
    Article Open access 01 May 2022
  19. Evaluation of effects of chronic nasal steroid use on rhinological symptoms of COVID-19 with SNOT-22 questionnaire

    Background

    The benefits of corticosteroids for the treatment of COVID-19 infection are documented in the literature. The goal of the study is to...

    Akif İşlek, Mustafa Koray Balcı in Pharmacological Reports
    Article 24 February 2021
  20. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease: clues to early diagnosis and effective treatment

    Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by movement dysfunction due to selective degeneration of...

    Yeo** Bang, Juhee Lim, Hyun ** Choi in Archives of Pharmacal Research
    Article Open access 19 June 2021
Did you find what you were looking for? Share feedback.